Yüklüyor......

ONC201: a new treatment option being tested clinically for recurrent glioblastoma

Glioblastoma is an aggressive central nervous system tumor with a 5-year-survival rate of less than 10%. Patients diagnosed with the disease are treated with surgery, radiation and temozolomide chemotherapy. Despite survival benefits, patients eventually relapse. There is a need for new treatments w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Cancer Res
Asıl Yazarlar: Ralff, Marie D., Lulla, Amriti R., Wagner, Jessica, El-Deiry, Wafik S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6117120/
https://ncbi.nlm.nih.gov/pubmed/30175049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tcr.2017.10.03
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!